Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Page

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Expert Opinion on Investigational Drugs|May 29, 2014
PDE inhibitors currently in early clinical trials for the treatment of asthmaMaria Gabriella Matera, Clive Page, Mario Cazzola
Respiratory Medicine|October 7, 2025
Sarcopenia as a treatable trait in COPD: From mechanisms to managementMaria Gabriella Matera, Clive Page, Mario Cazzola
Pulmonary Pharmacology & Therapeutics|January 1, 2013
Long-acting muscarinic receptor antagonists for the treatment of respiratory diseaseMario Cazzola, Clive Page, Maria Gabriella Matera
Current Opinion in Pharmacology|May 16, 2018
β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseasesMaria Gabriella Matera, Clive Page, Barbara Rinaldi
Nature Reviews. Drug Discovery|November 5, 2002
The future challenges facing the development of new antimicrobial drugsAnthony Coates, Yanmin Hu, Richard Bax, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 7, 2015
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and coughRaj Makwana, Radhakrishnan Venkatasamy, Domenico Spina, et al.
Handbook of Experimental Pharmacology|December 12, 2019
Perspectives of Pharmacology over the Past 100 YearsJames E Barrett, Clive Page, Martin C Michel
Trends in Pharmacological Sciences|September 28, 2007
Treating systemic effects of COPDMario Cazzola, Maria Gabriella Matera, Paola Rogliani, et al.
British Journal of Pharmacology|January 25, 2006
Mechanism of adenosine-induced airways obstruction in allergic guinea pigsSandra Keir, Victoria Boswell-Smith, Domenico Spina, et al.
Pharmaceutical Patent Analyst|January 19, 2019
Ensifentrine (RPL554): an inhaled 'bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary diseaseMario Cazzola, Clive Page, Luigino Calzetta, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Expert Opinion on Investigational Drugs|May 29, 2014
PDE inhibitors currently in early clinical trials for the treatment of asthmaMaria Gabriella Matera, Clive Page, Mario Cazzola
Respiratory Medicine|October 7, 2025
Sarcopenia as a treatable trait in COPD: From mechanisms to managementMaria Gabriella Matera, Clive Page, Mario Cazzola
Pulmonary Pharmacology & Therapeutics|January 1, 2013
Long-acting muscarinic receptor antagonists for the treatment of respiratory diseaseMario Cazzola, Clive Page, Maria Gabriella Matera
Current Opinion in Pharmacology|May 16, 2018
β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseasesMaria Gabriella Matera, Clive Page, Barbara Rinaldi
Nature Reviews. Drug Discovery|November 5, 2002
The future challenges facing the development of new antimicrobial drugsAnthony Coates, Yanmin Hu, Richard Bax, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 7, 2015
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and coughRaj Makwana, Radhakrishnan Venkatasamy, Domenico Spina, et al.
Handbook of Experimental Pharmacology|December 12, 2019
Perspectives of Pharmacology over the Past 100 YearsJames E Barrett, Clive Page, Martin C Michel
Trends in Pharmacological Sciences|September 28, 2007
Treating systemic effects of COPDMario Cazzola, Maria Gabriella Matera, Paola Rogliani, et al.
British Journal of Pharmacology|January 25, 2006
Mechanism of adenosine-induced airways obstruction in allergic guinea pigsSandra Keir, Victoria Boswell-Smith, Domenico Spina, et al.
Pharmaceutical Patent Analyst|January 19, 2019
Ensifentrine (RPL554): an inhaled 'bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary diseaseMario Cazzola, Clive Page, Luigino Calzetta, et al.
Pageof 11